Literature DB >> 31032664

The COPD Comorbidome in the Light of the Degree of Dyspnea and Risk of Exacerbation.

Juan Marco Figueira Gonçalves1, Miguel Ángel García Bello2, María Dolores Martín Martínez3, Lina Inmaculada Pérez Méndez2,4, Ignacio García-Talavera1, Sara García Hernández1, David Díaz Pérez1, Natalia Bethencourt Martín1.   

Abstract

The BODE group designed a bubble chart, analogous to the solar system, which depicts the prevalence of each disease and its association with mortality and called it a "comorbidome". Although this graph was used to represent mortality and, later, the risk of needing hospital admission, it was not applied to visualize the association between a set of comorbidities and the categories of the GOLD 2017 guidelines, neither according to the degree of dyspnea nor to the risk of exacerbation. For the purpose of knowing to which extent each comorbidity associates with each of the two conditions-most symptomatic group (groups B and D) and highest risk of exacerbation (groups C and D)-we performed a analysis based on the comorbidome. 439 patients were included. Cardiovascular comorbidity (especially cardiac and renal disease) is predominantly observed in patients with a higher degree of dyspnea, whereas bronchial asthma and stroke occur more frequently in subjects at higher risk of exacerbation. This is the first time that the comorbidome is presented based on the categories of the GOLD 2017 document, which we hope will serve as a stimulus for scientific debate.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Comorbidity; Comorbidome; Dyspnea; Exacerbation

Mesh:

Year:  2019        PMID: 31032664     DOI: 10.1080/15412555.2019.1592144

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  1 in total

1.  Characteristics of patients referred to Canary Island pneumology outpatient services for chronic obstructive pulmonary disease: the EPOCan study.

Authors:  Juan Marco Figueira-Gonçalves; José María Hernández-Pérez; Carlos Cabrera-López; Aurelio Luis Wangüemert-Pérez; Ignacio García-Talavera; Yolanda Ramallo-Fariña; Carolina Ramos-Izquierdo; Luis Manuel González-García; Sara Guanche-Dorta
Journal:  BMC Res Notes       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.